Decitabine

MAGE family member A1 ; Homo sapiens







16 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 28337274 Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes. 2017 2
2 28677424 Expansion of cancer germline antigen-specific cytotoxic T lymphocytes for immunotherapy. 2017 Jul 1
3 23266925 Complete remission following decitabine/dendritic cell vaccine for relapsed neuroblastoma. 2013 Jan 1
4 21626030 MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing. 2011 Sep 4
5 21725200 The depletion of DNA methyltransferase-1 and the epigenetic effects of 5-aza-2'deoxycytidine (decitabine) are differentially regulated by cell cycle progression. 2011 Aug 1
6 19259094 Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo. 2009 Mar 10 1
7 19421002 LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors. 2009 Apr 1 1
8 16687489 Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. 2006 May 1
9 16140943 Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. 2005 Sep 1 1
10 15256472 HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells. 2004 Jul 15 1
11 12123095 Expression spectrum and methylation-dependent regulation of melanoma antigen-encoding gene family members in pancreatic cancer cells. 2002 1
12 10523621 DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. 1999 Nov 2
13 9247253 Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease. 1997 Sep 2
14 8698626 Induction of MAGE genes in lymphoid cells by the demethylating agent 5-aza-2'-deoxycytidine. 1996 Jul 2
15 8707418 Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells. 1996 Jul 29 2
16 7511051 Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine. 1994 Apr 1 10